1. Home
  2. Browse Decisions
  3. N.J.
  4. 125 N.J.
  5. 125 N.J. 117 (1991)
 

FELDMAN v. LEDERLE LABORATORIES

125 N.J. 117 (1991)

592 A.2d 1176

CAROL ANN FELDMAN, PLAINTIFF-APPELLANT, v. LEDERLE LABORATORIES, A DIVISION OF AMERICAN CYANAMID COMPANY, A MAINE CORPORATION DOING BUSINESS IN THE STATE OF NEW JERSEY, DEFENDANT-RESPONDENT.

The Supreme Court of New Jersey.

Decided July 24, 1991.

Attorney(s) appearing for the Case

James I. Peck, IV, argued the cause for appellant.

William C. Slattery argued the cause for respondent (Morgan, Melhuish, Monaghan, Arvidson, Abrutyn & Lisowski and Norris, McLaughlin & Marcus, attorneys; Mr. Slattery and James L. Melhuish, of counsel).

Marc S. Klein argued the cause for amici curiae Pharmaceutical Manufacturers Association and E.R. Squibb & Sons, Inc. (Sills, Cummis, Zuckerman, Radin, Tischman, Epstein & Gross, attorneys).

John L. McGoldrick submitted a brief on behalf of amicus curiae Eli Lilly and Company (McCarter & English, attorneys).

The opinion of the Court was delivered by CLIFFORD, J.

In Feldman v. Lederle Laboratories, 97 N.J. 429, 479 A.2d 374 (1984) (Feldman I), we held that under the doctrine of strict products liability, "drug manufacturers have a duty to warn of dangers of which they know or should have known on the basis of reasonably obtainable or available knowledge." Id. at 434,

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases